Android app on Google Play

Nu Skin Enterprises (NUS) 'Powerful' Product Cycle Continues - Analyst

February 7, 2013 12:57 PM EST Send to a Friend
Get Alerts NUS Hot Sheet
Price: $44.72 -1.26%

Rating Summary:
    4 Buy, 3 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 3 | Down: 4 | New: 7
Trade NUS Now!
Join SI Premium – FREE
Despite getting lumped in with the Herbalife debate, Nu Skin Enterprises' (NYSE: NUS) remains in the "in the midst of a powerful product cycle," according to analyst at Canaccord Genuity. The firm reiterated a Buy rating but trimmed their price target from $65 to $55.

This was displayed in fourth quarter results, which came were in-line with recently raised guidance although FY2013 guidance pressured shares.

Analyst Scott Van Winkle said Q1 guidance looks conservative as it doesn't assume the yen hedge offset, but otherwise reflects the update provided in the company’s mid-January conference presentation.

The firm raised 2013E rev/EPS to $2.35B/$3.87 from $2.25B/$3.85. F2014E rev/EPS goes to $2.6B/$4.42 from $2.4B/$4.32.

For an analyst ratings summary and ratings history on Nu Skin Enterprises click here. For more ratings news on Nu Skin Enterprises click here.

Shares of Nu Skin Enterprises closed at $41.72 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Canaccord Genuity

Add Your Comment